Pfizer Inc.
Chemical Compounds
Last updated:
Abstract:
The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to HbS modulators of formula (I) ##STR00001## or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R.sup.2 and R.sup.3 are as defined in the description. HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).
Status:
Application
Type:
Utility
Filling date:
26 Nov 2019
Issue date:
4 Jun 2020